Skip to main content
View the latest BOT/BAL presentation from ESMO-GI

Corporate Presentation

Review Events

Upcoming & Recent Events

December 11, 2025 5:28 AM

Agenus End of Year 2025 Stakeholder Briefing Webcast Copy 2

Virtual Event
2025
Webcast
December 11, 2025 5:28 AM

Agenus End of Year 2025 Stakeholder Briefing Webcast Copy

Virtual Event
2025
Webcast
December 11, 2025 5:28 AM

Agenus End of Year 2025 Stakeholder Briefing Webcast

Virtual Event
2025
Webcast

Archived Events

Select Year
All Years
Link Template
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
December 11, 2025 5:28 AM

Agenus End of Year 2025 Stakeholder Briefing Webcast Copy 14

Virtual Event
2025
Webcast
December 11, 2025 5:28 AM

Agenus End of Year 2025 Stakeholder Briefing Webcast Copy 13

Virtual Event
2025
Webcast
December 11, 2025 5:28 AM

Agenus End of Year 2025 Stakeholder Briefing Webcast Copy 12

Virtual Event
2020
Webcast
December 11, 2025 5:28 AM

Agenus End of Year 2025 Stakeholder Briefing Webcast Copy 11

Virtual Event
2020
Webcast
December 11, 2025 5:28 AM

Agenus End of Year 2025 Stakeholder Briefing Webcast Copy 10

Virtual Event
2020
Webcast

Investor Email Alerts

Sign Up
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Contact Us

Agenus Inc.
investor@agenusbio.com

Quick Links

SEC Filings
Information Request Form
Request A Meeting With Management
Agenus Inc.
3 Forbes Road
Lexington, MA 02421-7305
T: +1 (781) 674 4400 | F: +1 (781) 674 4200
Our Science
Pipeline
Publications
Clinical Trials
Immunotherapy
About BOT + BAL
Company
Our History
Our Team
Careers
Partners
Access
Patient Access
Contact Medical Affairs
Resources
Press Releases
In the News
Patient Resources
FAQs
Investors
Investor Overview
Events
Financial Information
Opt-out preferencesCookie PolicyTerms and Conditions of UsePrivacy PolicyCommunity GuidelinesAccess to Investigational Medicines PolicyReport Adverse EventInvestor Portal
© 2025 Agenus Inc. All rights reserved.